Analysis and improvement measures of telephone drug consultation in a specialized hospital of obstetrics and gynaecology in China

Wang, Xianli; Pang, Yanyu; Sun, Hui; Huang, Yuanshen; Lin, Shizhou; Jin, Jing; Tang, Jing

doi:10.1111/jcpt.13253

Cited by 5 publications

(5 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In congruence with the Pareto principle, the influencing factors were categorized as follows: major factors within Category A (cumulative percentage 0-80%), minor factors in Category B (cumulative percentage 80-90%), and general factors within Category C (cumulative percentage 90-100%). 6…”

Section: Discussionmentioning

confidence: 99%

Assessing Compliance and Satisfaction Among Participants in Clinical Trials on Traditional Chinese Medicine

Xiao,

Androulakis,

Skelton

et al. 2024

OAJCT

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Assessing Compliance and Satisfaction Among Participants in Clinical Trials on Traditional Chinese Medicine

Xiao,

Androulakis,

Skelton

et al. 2024

OAJCT

View full text Add to dashboard Cite

“…To avoid bias in data processing and analysis, all data were assessed by two pharmacists independently. A discussion was held with a third pharmacist to resolve any discrepancies during data evaluation ( Wang et al, 2021 ).…”

Section: Methodsmentioning

confidence: 99%

Real-world pharmacological treatment of patients with postpartum depression in China from 2016 to 2020: A cross-sectional analysis

Sun

Wang

2022

Saudi Pharmaceutical Journal

Self Cite

View full text Add to dashboard Cite

“…However, according to an analysis of 1651 cases in tertiary hospitals in 10 provinces, the development of pharmaceutical consultations in obstetrics and gynaecology is far behind that in other departments [5]. Only Wang et al [6] studied telephone consultations conducted by clinical pharmacists in obstetrics and gynaecology hospitals. However, the content of the telephone consultations was quite different from that of clinical pharmacists' antiinfective consultations that are applied by physicians, which is of little relevance for infectious diseases.…”

Section: Introductionmentioning

confidence: 99%

Infection and the evaluation of biomarkers in obstetrics and gynecology patients with infectious disease: a retrospective observational study from clinical pharmacists’ consultation experience

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background The use of empirical anti-infective medication calls for the identification of common pathogens and accurate infectious biomarkers. However, clinical pharmacists’ anti-infective experience in the field of obstetrics and gynaecology is rare in the literature. This study aimed to retrospectively analyze the correlation between the anti-infective effectiveness after 7 days of antibiotic treatment and infectious biomarkers, according to clinical pharmacists’ consultation cases of gynecological and obstetric infections. Methods In this retrospective study, clinical pharmacists’ anti-infective consultation experiences applied by physicians from January 1, 2018, to December 31, 2020, were included. The exclusion criteria were as follows: (1) the patient died or left the hospital before undergoing an effectiveness evaluation after the consultation; (2) treatment was discontinued due to adverse reactions related to antibiotics; (3) the patient did not undergo an effectiveness evaluation within 3 or 7 days after application of the clinical pharmacist’s treatment plan; and (4) the physician did not adopt the clinical pharmacist’s suggestions. The registered information included patient characteristics, pathological bacteria, anti-infective medication and changes in infection indices before and after treatment. Statistical analysis of temperature, white blood cells (WBCs), C-reactive protein (CRP), procalcitonin (PCT) and WBCs in urine after 3 days and 7 days of anti-infective treatment, compared with before anti-infective treatment, was performed by the chi-square test. A t test was conducted to further study WBC count and CRP. A receiver operating characteristic curve verified the sensitivity and specificity of WBC count, CRP and PCT. Results A total of 265 cases were included. The CRP levels of patients 3 d and 7 d after antibiotic treatment were significantly lower than before antibiotic treatment (P < 0.05, P < 0.01), while the WBC count showed a downward trend after 3 days and a significant decrease after 7 days (P < 0.01). The areas under the curve (AUCs) for prognosis on the 7th day for WBC count, CRP and PCT were 0.90, 0.75 and 0.522, respectively. The AUC for WBC count combined with CRP was 0.90, which was higher than that for the biomarkers tested separately, especially compared to PCT. The most common gynecological infections were surgical site infection (SSI), urinary tract infection and fever of unknown origin, and the most common pathogens were E. coli and E. faecalis in Gram-negative and Gram-positive samples, respectively. Pharmacists’ recommended treatment plans included carbapenems and β-lactam antibiotics. Conclusions Our dual-center study indicates that the combination of WBC count and CRP can improve diagnostic accuracy and treatment efficiency, and PCT alone is insensitive to gynecological infections, according to clinical pharmacists’ experience.

show abstract

Analysis and improvement measures of telephone drug consultation in a specialized hospital of obstetrics and gynaecology in China

Cited by 5 publications

References 2 publications

Assessing Compliance and Satisfaction Among Participants in Clinical Trials on Traditional Chinese Medicine

Assessing Compliance and Satisfaction Among Participants in Clinical Trials on Traditional Chinese Medicine

Real-world pharmacological treatment of patients with postpartum depression in China from 2016 to 2020: A cross-sectional analysis

Infection and the evaluation of biomarkers in obstetrics and gynecology patients with infectious disease: a retrospective observational study from clinical pharmacists’ consultation experience

Contact Info

Product

Resources

About